Resultados de la búsqueda

Raposeiras-Roubin S, Rosselló X, Oliva B, Fernández-Friera L, Mendiguren JM, Andrés V, Bueno H, Sanz J, Martínez de Vega V, Abu-Assi E, Iñiguez A, Fernández-Ortiz A, Ibáñez B, Fuster V Triglycerides and Residual Atherosclerotic Risk J Am Coll Cardiol (2021) 77:3031-3041
Pocock SJ, Rossello X, Owen R, Collier TJ, Stone GW, Rockhold FW Primary and Secondary Outcome Reporting in Randomized Trials: JACC State-of-the-Art Review J Am Coll Cardiol (2021) 78:827-839
Kolte D, Yonetsu T, Ye JC, Libby P, Fuster V, Jang IK Optical Coherence Tomography of Plaque Erosion: JACC Focus Seminar Part 2/3 J Am Coll Cardiol (2021) 78:1266-1274
Aguirre AD, Arbab-Zadeh A, Soeda T, Fuster V, Jang IK Optical Coherence Tomography of Plaque Vulnerability and Rupture: JACC Focus Seminar Part 1/3 J Am Coll Cardiol (2021) 78:1257-1265
Rossello X, Ibanez B, Fuster V Reply: What Is Behind the HbA1c Value? J Am Coll Cardiol (2021) 78:e119
Escobar-Lopez L, Ochoa JP, Mirelis JG, Espinosa M, Navarro M, Gallego-Delgado M, Barriales-Villa R, Robles-Mezcua A, Basurte-Elorz MT, Gutiérrez García-Moreno L, Climent V, Jiménez-Jaimez J, Mogollón-Jiménez MV, Lopez J, Peña-Peña ML, García-Álvarez A, Brion M, Ripoll-Vera T, Palomino-Doza J, Tirón C, Idiazabal U, Brögger MN, García-Hernández S, Restrepo-Córdoba MA, Gonzalez-Lopez E, Méndez I, Sabater M, Villacorta E, Larrañaga-Moreira JM, Abecia A, Fernández AI, García-Pinilla JM, Rodríguez-Palomares JF, Gimeno-Blanes JR, Bayes-Genis A, Lara-Pezzi E, Domínguez F, Garcia-Pavia P Association of Genetic Variants With Outcomes in Patients With Nonischemic Dilated Cardiomyopathy J Am Coll Cardiol (2021) 78:1682-1699
Pascual-Figal DA Biochemical or clinical heart failure, not so simple Eur J Heart Fail (2021) 23:465-67
Lecce L, Xu Y, V'Gangula B, Chandel N, Pothula V, Caudrillier A, Santini MP, d'Escamard V, Ceholski DK, Gorski PA, Ma L, Koplev S, Bjørklund MM, Björkegren JL, Boehm M, Bentzon JF, Fuster V, Kim HW, Weintraub NL, Baker AH, Bernstein E, Kovacic JC Histone deacetylase 9 promotes endothelial-mesenchymal transition and an unfavorable atherosclerotic plaque phenotype J Clin Invest (2021) 131:e131178
Díaz-Munoz R, Valle-Caballero MJ, Sanchez-Gonzalez J, Pizarro G, García-Rubira JC, Escalera N, Fuster V, Fernández-Jiménez R, Ibanez B Intravenous metoprolol during ongoing STEMI ameliorates markers of ischemic injury: a METOCARD-CNIC trial electrocardiographic study Basic Res Cardiol (2021) 116:45
Link to the full text in Repisalud

Páginas